Postgraduate Medicine 1997: Vol 102 Index

11 Pages·1997·3 MB·English

POSTGRADUATE MEDICINE: JULY-DECEMBER 1997
| NDE X oe VOLUME
Subjects
ACNE AIRWAY OBSTRUCTION ¢ Lipid screening in children and adolescents to
¢ Dispelling myths—pathophysiologic factors, ¢ Aspiration pneumonia, strategies for early identify familial hypercholesterolemia. (GL)
types, and treatment. 102(2):94* recognition and prevention. 102(2):225* 102(1):218
ACQUIRED IMMUNODEFICIENCY SYNDROME: ALCOHOL ¢ Myocardial infarction, acute, recommenda-
See AIDS ¢ Use and abuse in pregnancy. 102(3):141 tions for medical management, role of primary
AGING ALCOHOLISM angioplasty. 102(3):159*
¢ Androgenetic alopecia, causes, diagnosis, and ¢ Cause of liver disease, issues around liver ¢ Reducing risk with vitamin E supplementa-
reatment. 102(2):129* transplantation. 102(6):108 tion. 102(2):199*
¢ Congestive heart failure in elderly patients, ARRHYTHMIAS: See Cardiovascular diseases ¢ Suspected myocardial infarction, role of car-
improving quality of life. 102(4):207* ARTHRITIS: See Rheumatic diseases diac markers in evaluation. 102(5):113*
« Costs of and theories of aging, future outlook. ¢ Venous thromboembolism, cost-effective ap-
(FT) 102(4):216* BEHAVIOR DISORDERS proach to diagnosis and treatment. 102(4):179*
« Drug compliance in the elderly, strategies for ¢ Pathological gambling, social and medical is- CHEMOTHERAPY: See Drugs, antineoplastic
improvement. 102(3):211* sue. (ED) 102(4):13 CHOLESTEROL
* Increasing immune response with supple- BIOPSY ¢ Lipid screening in children and adolescents,
mental vitamin E. 102(2):206 ¢ Suspicious lesions for skin cancer. 102(2):146 identifying patients with familial hypercholes-
* Nutritional needs. (PN) 102(5):227 BITES AND STINGS terolemia. (GL) 102(1):218
¢ Photoaged skin, overview of treatments and ¢ Insect repellents, safety and effectiveness, ¢ Management in patients with heart disease,
their effectiveness. 102(2):115* recommendations for optimal use. 102(2):63* increasing longevity with cholesterol-lowering
¢ Psychosis in late life, spotting new-onset BREAST DISEASES drug therapy. 102(2):81
disorders, options in drug therapy. 102(6):139* ¢ Mastalgia, causes, classification, and treat- COMPUTERS
¢ Seizures in the elderly, special issues in man- ment options. 102(5):183* ¢ Computerized medical record keeping and
agement. 102(1):168 new regulations from Health Care Financing Ad-
¢ Women with vulvar problems, identification CALCIUM ministration (HCFA). (DD) 102(6):28
and treatment. 102(3):121* ¢ Dietary, and calcium channel blockers, effect ¢ Computerizing patient education handouts for
AIDS on hypertension. 102(6):134 better distribution. (DD) 102(2):39
¢ Early diagnosis and treatment of primary HIV CANCER: See Neoplasms ¢ Document imaging in medicine to enhance
infection critical to outcome. 102(4):143* CARDIOVASCULAR DISEASES patient care. (DD) 102(1):19
¢ HIV and healthcare workers, ways to reduce ¢ Acute myocardial infarction, new recommen- ¢ Intranets, how they work and how to set them
risks of transmission. 102(4):155* dations for prompt management. 102(5):84* up. (DD) 101(4):33
¢ Molluscum contagiosum in patient with AIDS, ¢ Acute myocardial! infarction, pharmacologic ¢ Push technology in medical practice. (DD)
special treatment considerations for immuno- therapy, summary of clinical findings. 102(5): 102(3):47
deficient individuals. (PP) 102(6):41 143* e Voice-recognition technology, uses in medi-
¢ Opportunistic infections, prevention and treat- ¢ Acute myocardial infarction, thrombolytic cine. (DD) 102(5):39
ment. 102(4):125* therapy versus primary angioplasty. 102(5):97* CONNECTIVE TISSUE DISEASE
¢ Arrhythmias after acute myocardial infarction, ¢ Coexistent with peripheral neuropathy, essen-
evaluation and management. 102(5):125* tials of diagnosis and treatment. 102(5):65*
*Major clinical discussion ¢ Cardiac involvement in rheumatic fever, diag- COST-BENEFIT ANALYSIS
CR, Case Report nosis and treatment. (CR) 102(6):65 * Economic effects of managed care, how phy-
DD, Digital Doc ¢ Cholesterol management to increase longev- sicians, hospitals, patients, and others are far-
ED, Editorial ity, therapeutic options. 102(2):81* ing. (ED) 102(5):13
FT, Feature ¢ Congestive heart failure in elderly patients, CRITICAL CARE
GL, Clinical Practice Guidelines improving quality of life. 102(4):207* ¢ Oliguric renal failure in critically ill patients,
PH, Physician-at-Large ¢ Coronary heart disease, historical overview. treatment. 102(3):245*
PN, Patient Notes (FT) 102(2):210*
PP, Puzzles in Practice ¢ Hypertension, treatment with calcium channel
VP, Viewpoint blockers, questions about long-term safety.
102(6):127*
156 VOL 102 / NO 6 / DECEMBER 1997 / POSTGRADUATE MEDICINE
POSTGRADUATE MEDICINE: JULY-DECEMBER 1997
| NDE X oe VOLUME
Subjects
ACNE AIRWAY OBSTRUCTION ¢ Lipid screening in children and adolescents to
¢ Dispelling myths—pathophysiologic factors, ¢ Aspiration pneumonia, strategies for early identify familial hypercholesterolemia. (GL)
types, and treatment. 102(2):94* recognition and prevention. 102(2):225* 102(1):218
ACQUIRED IMMUNODEFICIENCY SYNDROME: ALCOHOL ¢ Myocardial infarction, acute, recommenda-
See AIDS ¢ Use and abuse in pregnancy. 102(3):141 tions for medical management, role of primary
AGING ALCOHOLISM angioplasty. 102(3):159*
¢ Androgenetic alopecia, causes, diagnosis, and ¢ Cause of liver disease, issues around liver ¢ Reducing risk with vitamin E supplementa-
reatment. 102(2):129* transplantation. 102(6):108 tion. 102(2):199*
¢ Congestive heart failure in elderly patients, ARRHYTHMIAS: See Cardiovascular diseases ¢ Suspected myocardial infarction, role of car-
improving quality of life. 102(4):207* ARTHRITIS: See Rheumatic diseases diac markers in evaluation. 102(5):113*
« Costs of and theories of aging, future outlook. ¢ Venous thromboembolism, cost-effective ap-
(FT) 102(4):216* BEHAVIOR DISORDERS proach to diagnosis and treatment. 102(4):179*
« Drug compliance in the elderly, strategies for ¢ Pathological gambling, social and medical is- CHEMOTHERAPY: See Drugs, antineoplastic
improvement. 102(3):211* sue. (ED) 102(4):13 CHOLESTEROL
* Increasing immune response with supple- BIOPSY ¢ Lipid screening in children and adolescents,
mental vitamin E. 102(2):206 ¢ Suspicious lesions for skin cancer. 102(2):146 identifying patients with familial hypercholes-
* Nutritional needs. (PN) 102(5):227 BITES AND STINGS terolemia. (GL) 102(1):218
¢ Photoaged skin, overview of treatments and ¢ Insect repellents, safety and effectiveness, ¢ Management in patients with heart disease,
their effectiveness. 102(2):115* recommendations for optimal use. 102(2):63* increasing longevity with cholesterol-lowering
¢ Psychosis in late life, spotting new-onset BREAST DISEASES drug therapy. 102(2):81
disorders, options in drug therapy. 102(6):139* ¢ Mastalgia, causes, classification, and treat- COMPUTERS
¢ Seizures in the elderly, special issues in man- ment options. 102(5):183* ¢ Computerized medical record keeping and
agement. 102(1):168 new regulations from Health Care Financing Ad-
¢ Women with vulvar problems, identification CALCIUM ministration (HCFA). (DD) 102(6):28
and treatment. 102(3):121* ¢ Dietary, and calcium channel blockers, effect ¢ Computerizing patient education handouts for
AIDS on hypertension. 102(6):134 better distribution. (DD) 102(2):39
¢ Early diagnosis and treatment of primary HIV CANCER: See Neoplasms ¢ Document imaging in medicine to enhance
infection critical to outcome. 102(4):143* CARDIOVASCULAR DISEASES patient care. (DD) 102(1):19
¢ HIV and healthcare workers, ways to reduce ¢ Acute myocardial infarction, new recommen- ¢ Intranets, how they work and how to set them
risks of transmission. 102(4):155* dations for prompt management. 102(5):84* up. (DD) 101(4):33
¢ Molluscum contagiosum in patient with AIDS, ¢ Acute myocardial! infarction, pharmacologic ¢ Push technology in medical practice. (DD)
special treatment considerations for immuno- therapy, summary of clinical findings. 102(5): 102(3):47
deficient individuals. (PP) 102(6):41 143* e Voice-recognition technology, uses in medi-
¢ Opportunistic infections, prevention and treat- ¢ Acute myocardial infarction, thrombolytic cine. (DD) 102(5):39
ment. 102(4):125* therapy versus primary angioplasty. 102(5):97* CONNECTIVE TISSUE DISEASE
¢ Arrhythmias after acute myocardial infarction, ¢ Coexistent with peripheral neuropathy, essen-
evaluation and management. 102(5):125* tials of diagnosis and treatment. 102(5):65*
*Major clinical discussion ¢ Cardiac involvement in rheumatic fever, diag- COST-BENEFIT ANALYSIS
CR, Case Report nosis and treatment. (CR) 102(6):65 * Economic effects of managed care, how phy-
DD, Digital Doc ¢ Cholesterol management to increase longev- sicians, hospitals, patients, and others are far-
ED, Editorial ity, therapeutic options. 102(2):81* ing. (ED) 102(5):13
FT, Feature ¢ Congestive heart failure in elderly patients, CRITICAL CARE
GL, Clinical Practice Guidelines improving quality of life. 102(4):207* ¢ Oliguric renal failure in critically ill patients,
PH, Physician-at-Large ¢ Coronary heart disease, historical overview. treatment. 102(3):245*
PN, Patient Notes (FT) 102(2):210*
PP, Puzzles in Practice ¢ Hypertension, treatment with calcium channel
VP, Viewpoint blockers, questions about long-term safety.
102(6):127*
156 VOL 102 / NO 6 / DECEMBER 1997 / POSTGRADUATE MEDICINE
DELIVERY OF HEALTHCARE ¢ For cholesterol management in patients with ¢ Interferon, for chronic hepatitis C virus infec-
¢ Dangers of diagnostic labels. (VP) 102(2):161 heart disease, therapeutic options. 102(2):84* tion. 102(5):206
¢ Document imaging in medicine to enhance ¢ For congestive heart failure in the elderly, ¢ Interferon therapy for hepatitis C. 102(6):97
patient care. (DD) 102(1):19 special considerations. 102(4):212 DRUGS, BETA BLOCKER
¢ Economic effects of managed care. (ED) ¢ For seizures and epilepsy, overview of five ¢ Following acute myocardial infarction. 102(5):
102(5):13 new agents. 102(1):147* 149
¢ Ethics of managed care. (ED) 102(3):15 ¢ Maximizing compliance in the elderly. 102(3): ¢ For acute myocardial infarction. 102(3):159
¢ Guidelines for prompt and effective manage- 211* DRUGS, CALCIUM CHANNEL BLOCKER
ment of acute myocardial infarction, recent rec- DRUGS, ACE INHIBITOR ¢ For hypertension, questions about long-term
ommendations. 102(5):84* ¢ For acute myocardial infarction. 102(3):166 safety. 102(6):127*
¢ Physician organizations, perhaps a viable al- ¢ Role after acute myocardial infarction, results DRUGS, CHOLESTEROL-LOWERING
ternative to today’s HMOs. (ED) 102(2):13 of studies. 102(5):150 ¢ For secondary prevention of coronary heart
¢ Risk of HIV transmission to healthcare work- DRUGS, ANTIBIOTIC disease. 102(2):87
ers, reducing risks and managing exposures. ¢ For acute sinusitis. 102(2):255 DRUGS, DIURETIC
102(4):155* ¢ For community-acquired pneumonia, recom- ¢ For oliguria in critically ill patients. 102(3):246
DENTAL DISEASE mendations. 102(6):56 DRUGS, HORMONE
¢ In patients with diabetes, importance of care- ¢ Topical and oral, effectiveness against acne. ¢ Estrogen replacement therapy. (PN) 102(3):290
ful examination. 102(6):117* 102(2):103 DRUGS, NITRATE
DEPRESSION DRUGS, ANTICOAGULANT ¢ Nitroglycerin for acute myocardial infarction.
¢ Recognition and management in primary care ¢ For venous thromboembolism. 102(4):187 102(5):143
practice. 102(2):219* ¢ Heparin, for acute myocardial infarction. DRUGS, NONPRESCRIPTION
DIABETES 102(3):165 * Topical remedies for acne. 102(2):97
¢ Cause of peripheral neuropathy, classification DRUGS, ANTIEPILEPTIC DRUGS, THROMBOLYTIC
and management. 102(3):81 ¢ Cause of fetal malformations. 102(1):128 ¢ For acute myocardial infarction. 102(3):160
¢ Oral complications, importance of careful ¢ Five new agents—felbamate, fosphenytoin, ¢ For myocardial infarction, comparisons with
screening. 102(6):117* gabapentin, lamotrigine, topiramate. 102(1):147* angioplasty. 102(5):97*
DIAGNOSTIC TECHNIQUES ¢ For seizures in special populations, treatment e For myocardial infarction, updated recom-
¢ Cardiac markers, role in evaluation of sus- considerations. 102(1):165 mendations. 102(5):87
pected myocardial infarction. 102(5):113* ¢ Issues in initiating and discontinuing treat- ¢ For venous thromboembolism. 102(4):192
¢ Diagnostic imaging, historical overview. (FT) ment in patients with seizures and epilepsy. DRUGS, TOPICAL
102(6):144 102(1):102 Antiacne, effectiveness and costs. 102(2):98
¢ For degenerative joint disease of the knee in DRUGS, ANTINEOPLASTIC
adults. (GL) 102(5):173 ¢ Chemotherapy as follow-up to surgery for EDUCATION, MEDICAL
¢ For identification of hepatitis C virus. 102(5):202 ovarian cancer. 102(3):117 ¢ Effect of federal support, implications for fu-
¢ For pulmonary embolism and deep venous ¢ Chemotherapy for gastric cancer. 102(4):236 ture. (ED) 102(6):15
thrombosis. 102(4):179* DRUGS, ANTIPLATELET ELBOW
¢ In evaluation of congestive heart failure in the ¢ Aspirin after acute myocardial infarction, re- ¢ Tennis, diagnosis and treatment. 102(4):81
elderly. 102(4):208 sults of studies. 102(5):148 ELDERLY: See Aging
¢ Nerve conduction studies in diagnosis of pe- DRUGS, ANTIRETROVIRAL EMERGENCY MEDICINE
ripheral neuropathy. 102(3):80 ¢ For HIV infection, successes and continuing ¢ Acute myocardial infarction, updated manage-
¢ Routine screening for colorectal cancer, pros challenges with its use. 102(4):100* ment guidelines from ACC and AHA. 102(5):84*
and cons. 102(1):48* ¢ Impact on opportunistic infections in patients ¢ Oliguria in critically ill patients, treatment.
DIET: See Nutrition with AIDS. 102(4):135 102(3):245*
DRUG ABUSE ¢ In pregnancy. 102(4):169 ENDOCRINE DISORDERS
e In pregnancy, detection, intervention, and ¢ Postexposure prophylaxis with zidovudine to * Cause of peripheral neuropathy, diagnosis
support. 102(3):135* prevent HIV infection. 102(4):149 and management. 102(3):105
DRUG THERAPY ¢ Zidovudine for primary HIV infection. 102(4): * Diabetes: See Diabetes
¢ For acute myocardial infarction. 102(3):159 149 EPILEPSY
¢ For acute myocardial infarction, overview of DRUGS, ANTIVIRAL ¢ Five new antiepileptic drugs, overview.
studies and findings from clinical experience. ¢ For varicella-zoster virus infection. 102(1): 102(1):147*
102(5):143* 187 ¢ In children, the elderly, and patients with co-
continued
VOL 102 / NO 6 / DECEMBER 1997 / POSTGRADUATE MEDICINE 157
INDEX TO VOLUME 102 CONTINUED
existent medical illness, special management HAND e Vaccines for hepatitis A and B, latest recom-
considerations. 102(1):165* ¢ Carpal tunnel syndrome, diagnosis and treat- mendations. 102(6):74*
¢ Issues in medical and surgical treatment. ment. 102(4):72 ¢ Varicella virus vaccine. 102(1):188
102(1):102* ¢ Trigger finger, diagnosis and treatment. IMMUNOLOGIC DISEASES
¢ Special issues related to women with epilep- 102(4):75 ¢ AlDS-related infections, prevention and treat-
sy. 102(1):123* HEALTH POLICY ment. 102(4):125*
ETHICS, MEDICAL ¢ Managed care, ethical issues. (ED) 102(3):15 ¢ HIV infection, successes and challenges of
¢ Ethical challenges for physicians in managed HEART DISEASE: See Cardiovascular diseases antiretroviral therapy. 102(4):100*
care environments. (ED) 102(2):13 HEMATOLOGIC DISEASES ¢ Peripheral neuropathy and connective tissue
¢ Ethics of managed care. (ED) 102(3):15 ¢ Multiple myeloma, case presenting with inca- disease, essentials of diagnosis and treatment.
¢ Mandatory HIV screening in pregnant women. pacitating arthralgias. (CR) 102(4):197 102(5):65*
102(1):84 HEPARIN INFANTS
¢ As adjunct to thrombolysis in acute myocar- ¢ HIV infection, special concerns in care and
FEVER dial infarction. 102(3):165 prevention. 102(4):165
e Rheumatic, diagnosis using Jones criteria, HEPATITIS INFECTION
treatment. (CR) 102(6):65 ¢ A and B, vaccines, latest recommendations. e Active sepsis or infection with HIV, con-
102(6):74* traindications for liver transplantation. 102(6):
GASTROINTESTINAL DISEASES ¢ B infection, contraindications for liver trans- 104
¢ Colorectal cancer, arguments for and against plantation. 102(6):105 ¢ Acute bacterial sialadenitis of the subman-
routine screening. 102(1):48* ¢ C, controversies in diagnosis and treatment. dibular glands, diagnosis and treatment. (PP)
¢ Enterobius vermicularis, or pinworms, diag- 102(5):201* 102(4):93
nosis and treatment. (PP) 102(5):37 ¢ C, diagnosis and management, from trans- ¢ Bacterial pneumonia following aspiration of
¢ Gastric cancer, update on diagnosis, staging, mission to long-term follow-up. 102(6):95* oropharyngeal flora. 102(2):229
and therapy. 102(4):231* HEREDITARY DISEASES ¢ Causes of vulvar problems in elderly women,
¢ Irritable bowel syndrome, danger of diagnos- ¢ Hereditary hemochromatosis, diagnosis and identification and treatment. 102(3):121
tic labels. (VP) 102(2):161 treatment. 102(6):83* ¢ Enterobius vermicularis, or pinworms, diag-
¢ Irritable bowel syndrome, guidelines for effec- HISTORY OF MEDICINE nosis and treatment. (PP) 102(5):37
tive diagnosis and treatment. 102(3):197* ¢ Cancer, historical overview. (FT) 102(3):232 ¢ Helicobacter pylori, putting it in perspective.
¢ Peptic ulcer disease, historical overview. (FT) ¢ Coronary artery disease, historical overview. (FT) 102(5):161
102(5):158 (FT) 102(2):210* ¢ Hepatitis A and B, latest recommendations on
¢ Strongyloidiasis, diagnosis and treatment. ¢ Diagnostic imaging, historical overview. (FT) vaccination. 102(6):74*
102(3):177* 102(6):144 e Hepatitis C, controversies in diagnosis and
GENETIC DISORDERS: See Hereditary diseases ¢ Historical look at peptic ulcer disease. (FT) treatment. 102(5):201*
GENITAL DISEASES 102(5):158 ¢ Hepatitis C, diagnosis and management, from
¢ Vulvar problems in elderly women, identifica- * Overview of aging, with look at costs and the- transmission to long-term follow-up. 102(6):
tion and treatment. 102(3):121* ories of aging. (FT) 102(4):216* 95*
GERIATRICS: See Aging ¢ Pain, historical overview of problem and its e HIV and occupational risk, ways to protect
GUIDELINES, CLINICAL PRACTICE management. (FT) 102(1):198* healthcare workers. 102(4):155*
¢ Cervical cancer screening. (GL) 102(3):185 HORMONES ¢ HIV, antiretroviral therapy, successes and
¢ Degenerative joint disease of the knee in ¢ Estrogen replacement therapy. (PN) 102(3):290 continuing challenges with its use. 102(4):100*
adults, diagnosis and treatment. (GL) 102(5): HOSPITALS, COMMUNITY ¢ HIV, in women and children, special concerns
167* ¢ Management of acute myocardial infarction, in care and prevention. 102(4):165*
¢ Lipid screening in children and adolescents, updated guidelines from AHA and ACC. 102(5): e HIV, screening pregnant women, pros and
identifying patients with familial hypercholes- 91 cons. 102(1):77*
terolemia. (GL) 102(1):218 HYPERTENSION: See Cardiovascular diseases e Lyme disease, serologic testing. 102(1):65*
GYNECOLOGY: See Obstetrics/Gynecology HYPOTHERMIA ¢ Molluscum contagiosum, diagnosis and treat-
¢ Patient information. (PN) 102(4):275 ment. (PP) 102(6):41
HAIR DISEASES ¢ Opportunistic, in patients with AIDS, preven-
¢ Androgenetic alopecia, causes, diagnosis, and IMMUNIZATION tion and treatment. 102(4):125*
treatment. 102(2):129* ¢ Poliovirus vaccination, new recommenda- ¢ Poliovirus, new vaccination recommenda-
tions. 102(5):45* tions. 102(5):45*
VOL 102 / NO 6 / DECEMBER 1997 / POSTGRADUATE MEDICINE
¢ Primary HIV, clinical features and laboratory ¢ Of primary HIV infection. 102(4):144 Cancer, historical overview. (FT) 102(3):232
tests for early diagnosis and treatment. 102(4): * Role of cardiac markers in evaluation of sus- * Cervical, screening for cancer. (GL) 102(3):185
143* pected myocardial infarction, comparison of ef- * Colorectal cancer, rationale for and against
¢ Psittacosis, transmission, clinical features, di- fectiveness. 102(5):113* routine screening. 102(1):48*
agnosis, and treatment. 102(2):181* ¢ Screening for HIV in pregnant women, pros ¢ Gastric cancer, update on diagnosis, staging,
¢ Rheumatic fever, diagnosis using Jones crite- and cons. 102(1):77* and therapy. 102(4):231*
ria, treatment. (CR) 102(6):65 ¢ Serum HCV antibodies and diagnosis of hep- ¢ Malignant tumors, contraindications to liver
* Sinusitis, acute, in adults, diagnosis and man- atitis C. 102(6):96 transplantation. 102(6):105
agement. 102(2):253* LARYNGITIS ¢ Multiple myeloma, case presenting with inca-
¢ Strongyloidiasis, diagnosis and treatment. ¢ Patient information. (PN) 102(6):176 pacitating arthralgias. (CR) 102(4):197
102(3):177* LIVER DISEASES ¢ Ovarian cancer, screening, prevention, and
¢ Varicella-zoster virus, new developments in e End-stage, role of liver transplantation, indi- management. 102(3):112*
prevention and treatment. 102(1):187* cations and contraindications. 102(6):103* * Paget's disease of vulva. 102(3):131
INFLAMMATION ¢ Hepatitis A and B, latest recommendations on ¢ Prevention, role of vitamin E supplementa-
¢ Laryngitis, causes and treatment. (PN) vaccination. 102(6):74* tion. 102(2):200
102(6):176 ¢ Hepatitis C, controversies in diagnosis and ¢ Vulvar intraepithelial neoplasia. 102(3):125
INJURIES: See Trauma treatment. 102(5):201* NEUROLOGIC MANIFESTATIONS
INSECT REPELLENTS * Role of hemochromatosis, diagnosis and ¢ Epilepsy, issues in medical and surgical treat-
¢ Safety and effectiveness, recommendations treatment. 102(6):83* ment. 102(1):102*
for optimal use. 102(2):63* ¢ Role of hepatitis C, diagnosis and manage- ¢ Epilepsy, treatment with five new antiepileptic
INTERFERON ment. 102(6):95* drugs. 102(1):147*
¢ For chronic hepatitis C virus infection. 102(5): LUNG DISEASES ¢ Epilepsy, women’s issues related to menses,
206 ¢ Aspiration pneumonia, strategies for early birth control, pregnancy, childcare, and so on.
¢ Therapy for hepatitis C. 102(6):97 recognition and prevention. 102(2):225* 102(1):123*
IRON ¢ Neuropsychological deficits in psychotic mood
¢ Hereditary hemochromatosis, diagnosis and MEDICAL PRACTICE disorders in the elderly, drug therapy. 102(6):
treatment. 102(6):83* ¢ Computerizing patient education handouts for 140
better distribution. (DD) 102(2):39 ¢ Pain: See Pain
JOINTS ¢ Ethics of managed care. (ED) 102(3):15 ¢ Peripheral neuropathy and connective tissue
¢ Degenerative joint disease of the knee in ¢ Use and impact of voice-recognition comput- disease, essentials of diagnosis and treatment.
adults, diagnosis and treatment. (GL) 102(5): er technology. (DD) 102(5):39 102(5):65*
167 MOUTH DISEASES ¢ Peripheral neuropathy, clues to underlying
¢ Acute bacterial sialadenitis of the subman- cause. 102(3):71*
KIDNEY DISEASES dibular glands, diagnosis and treatment. (PP) ¢ Peripheral neuropathy, endocrinologic causes,
¢ Chronic renal failure, peripheral neuropathy, 102(4):93 identifying source and providing symptomatic
presentations and therapeutic approaches. ¢ Oral complications in patients with diabetes. relief. 102(3):81*
102(4):249* 102(6):117* ¢ Peripheral neuropathy in patients with chronic
* Oliguria in critically ill patients, treatment. MUSCULOSKELETAL DISORDERS renal failure, presentations and therapeutic ap-
102(3):245* ¢ Degenerative joint disease of the knee in proaches. 102(4):249*
KNEE adults, diagnosis and treatment. (GL) 102(5):167 * Sciatica. (PN) 102(1):234
¢ Degenerative joint disease in adults, diagnosis ¢ Repetitive strain injuries, overview of the ¢ Seizures in special populations, management.
and treatment to maximize function and pro- problem and the patients. 101(4):53* 102(1):165*
mote joint health. (GL) 102(5):167 ¢ Repetitive strain injury, diagnostic and treat- ¢ Thoracic outlet syndrome, diagnosis and
ment tips. 102(4):72* treatment. 102(4):81
LABORATORY INVESTIGATION * Sciatica. (PN) 102(1):234 NUTRITION
* Clinical staging of HIV infection to assess dis- MYOCARDIAL INFARCTION: See Cardiovascu- ¢ Dietary changes for patients with irritable
ease status. 102(4):100 lar diseases bowel syndrome. 102(3):204
¢ For early diagnosis of hemochromatosis. e In the elderly. (PN) 102(5):227
102(6):85 NEOPLASMS ¢ Role of diet in preventing oral disease in pa-
¢ In psittacosis. 102(2):187 ¢ Basal and squamous cell carcinomas, charac- tients with diabetes. 102(6):121
¢ Lyme disease, serologic testing, pitfalls in di- teristics, diagnostic and therapeutic options. ¢ Vitamin E, supplemental, benefits. 102(2):199
agnosis. 102(1):65* 102(2):139 continued
VOL 102 / NO 6 / DECEMBER 1997 / POSTGRADUATE MEDICINE 159
INDEX TO VOLUME 102 CONTINUED
OBSTETRICS/GYNECOLOGY ¢ With posttransplant drug protocol, factor in ¢ Community-acquired, from psittacosis, diag-
¢ Cervical cancer screening. (GL) 102(3):185 whether to undergo liver transplantation. nosis and treatment. 102(2):181
¢ HIV infection in pregnant women, special 102(6):105 PREGNANCY: See Obstetrics/Gynecology
concerns. 102(4):165 PATIENT EDUCATION PREVENTIVE MEDICINE
¢ Hysterectomy, guidelines for surgical options. e Acne, importance of dispelling myths. ¢ Lipid screening in children and adolescents to
102(3):153* 102(2):94* identify patients with familial hypercholes-
¢ Ovarian cancer, screening, prevention, and ¢ Computerizing handouts for better distribu- terolemia. (GL) 102(1):218
management. 102(3):112* tion. (DD) 102(2):39 ¢ Polio immunization, new recommendations.
¢ Pregnancy and substance abuse, detection, ¢ Counseling women to avoid substance use in 102(5):45*
intervention, and support. 102(3):135* pregnancy. 102(3):135 ¢ Protecting yourself from sun and skin cancer.
¢ Pregnancy in patients with epilepsy, special ¢ Degenerative joint disease of the knee in 102(2):152
measures, fetal effects. 102(1):128 adults. (GL) 102(5):169 ¢ Routine screening for colorectal cancer, pros
¢ Vulvar problems in elderly women, identifica- ¢ For self-management of degenerative joint and cons. 102(1):48*
tion and treatment. 102(3):121* disease of the knee. (GL) 102(5):177 ¢ Screening for HIV in pregnant women, pros
OCCUPATIONAL DISEASES ¢ Hormone replacement therapy. (PN) 102(3): and cons. 102(1):77*
¢ HIV and healthcare workers, ways to reduce 290 ¢ Supplemental vitamin E, potential benefits.
risks of transmission. 102(4):155* ¢ Hypothermia. (PN) 102(4):275 102(2):199*
¢ Repetitive strain injury, overview of the prob- ¢ Itching, causes and management. (PN) ¢ Tips on preventing repetitive strain injury.
lem and the patients. 101(4):53* 102(2):284 102(4):68
¢ Six repetitive strain injuries, diagnostic and ¢ Laryngitis, causes and treatment. (PN) PSYCHIATRIC/PSYCHOSOCIAL DISORDERS
treatment tips. 102(4):72* 102(6):176 ¢ Depression, recognition and management.
OTORHINOLARYNGOLOGIC DISEASES ¢ Nutrition in the elderly. (PN) 102(5):227 102(2):219*
¢ Acute bacterial sialadenitis of the subman- ¢ Protection measures for upper-body joints, e Pathological gambling, social and medical is-
dibular glands, diagnosis and treatment. (PP) patient information. 102(4):73 sue. (ED) 102(4):13
102(4):93 ¢ Sciatica. (PN) 102(1):234 ¢ Psychological impact of diagnosis of HIV in-
¢ Laryngitis, causes and treatment. (PN) PEDIATRICS fection. 102(4):146
102(6):176 ¢ HIV infection in infants and children, special ¢ Psychotic disorders in late life, diagnosis,
¢ Sinusitis, acute, in adults, diagnosis and man- concerns in care and prevention. 102(4):165 newest options in drug therapy. 102(6):139*
agement. 102(2):253* ¢ Lipid screening in children and adolescents to ¢ Role of psychological abnormalities in patho-
identify patients with familial hypercholes- genesis of fibromyalgia and irritable bowel syn-
PAIN terolemia. (GL) 102(1):218 drome. (VP) 102(2):175
¢ Breast, causes, evaluation, and treatment. ¢ Poliovirus vaccination, new recommenda- ¢ Role of psychological factors in irritable
102(5):183* tions. 102(5):45* bowel syndrome. 102(3):202
¢ Historical overview of problem and its man- ¢ Seizures in children, special issues in man- ¢ Substance abuse in pregnancy, detection, in-
agement. (FT) 102(1):198* agement. 102(1):165 tervention, and support. 102(3):135*
¢ In diabetic neuropathy, causes and manage- ¢ Vaccines for hepatitis A and B, latest recom- PUBLIC HEALTH
ment. 102(3):90 mendations. 102(6):74* ¢ Community-acquired pneumonia, public
* Management, in degenerative joint disease of PHYSICIANS health implications, diagnosis and treatment.
the knee. (GL) 102(5):177 ¢ Future of graduate medical education, effects 102(6):45*
¢ Myofascial disorders, diagnosis and treat- of federal support. (ED) 102(6):15
ment. 102(4):85 ¢ Managed care, economic effects. (ED) RADIOLOGIC DIAGNOSIS
¢ Peripheral neuropathy, clues to underlying 102(5):13 ¢ Diagnostic imaging, historical overview. (FT)
cause. 102(3):71* ¢ Organizations, alternative to current HMOs? 102(6):144
¢ Sciatica. (PN) 102(1):234 (ED) 102(2):13 RADIOTHERAPY
PARASITIC DISEASES ¢ Volunteerism, opportunities and rewards. ¢ For gastric cancer. 102(4):235
¢ Enterobius vermicularis, or pinworms, diag- (ED) 102(1):13 RECTAL DISEASES
nosis and treatment. (PP) 102(5):37 PNEUMONIA ¢ Enterobius vermicularis, diagnosis and treat-
¢ Strongyloidiasis, diagnosis and treatment. ¢ Aspiration, strategies for early recognition ment. (PP) 102(5):37
102(3):177* and prevention. 102(2):225* RENAL DISEASES: See Kidney diseases
PATIENT COMPLIANCE ¢ Community-acquired, cost-conscious ap- RENAL FAILURE: See Kidney diseases
¢ Maximizing drug compliance in the elderly. proach to diagnosis and treatment. 102(6):45*
102(3):211*
160 VOL 102 / NO 6 / DECEMBER 1997 / POSTGRADUATE MEDICINE
RESPIRATORY DISEASES SHOULDER THERAPEUTICS
¢ Aspiration pneumonia, strategies for early ¢ Impingement syndrome, diagnosis and treat- ¢ Phlebotomies for iron overload in patients
recognition and prevention. 102(2):225* ment. 102(4):78 with hemochromatosis. 102(6):90
¢ Community-acquired pneumonia, cost- SINUSITIS ¢ Primary angioplasty, role in management of
conscious approach to diagnosis and treatment. ¢ Acute, in adults, diagnosis and management. acute myocardial infarction. 102(3):171
102(6):45* 102(2):253* ¢ Primary percutaneous transiumina! coronary
¢ Psittacosis, transmission, clinical features, di- SKIN DISEASES angioplasty for acute myocardial infarction,
agnosis, and treatment. 102(2):181* ¢ Acne, pathophysiologic factors, types, and comparison with thrombolytic therapy. 102(5):
RHEUMATIC DISEASES treatment. 102(2):94* 97*
¢ Arthralgias in patient with multiple myeloma, ¢ Androgenetic alopecia, causes, diagnosis, and TRANSPLANTATION
report of case. (CR) 102(4):197 treatment. 102(2):129* ¢ Liver, patient referral, indications and con-
¢ Connective tissue disease and peripheral neu- ¢ Basal and squamous cell carcinomas, charac- traindications. 102(6):103*
ropathy, essentials of diagnosis and treatment. teristics, diagnostic and therapeutic options. ¢ Renal, effect on polyneuropathy in patients
102(5):65* 102(2):139* with chronic renal failure. 102(4):256
¢ Degenerative joint disease of the knee in ¢ Effects of insect repellents on skin. 102(2):63 TRAUMA
adults, diagnosis and treatment. (GL) 102(5):167 ¢ Itching, causes and management. (PN) ¢ Hypothermia. (PN) 102(4):275
¢ Fibromyalgia, danger of diagnostic labels. 102(2):284 ¢ Needlestick injuries and HIV, reducing risks of
(VP) 102(2):161 ¢ Molluscum contagiosum, diagnosis and treat- transmission. 102(4):156
¢ Lyme disease, serologic testing. 102(1):65* ment. (PP) 102(6):41 ¢ Repetitive strain injuries, diagnostic and treat-
¢ Rheumatic fever, diagnosis using Jones crite- ¢ Photoaged skin, overview of topical treat- ment tips. 102(4):72*
ria, treatment. (CR) 102(6):65 ments and their effectiveness. 102(2):115* ¢ Repetitive strain injury, overview of the prob-
SMOKING lem and the patients. 101(4):53*
SCREENING ¢ In pregnancy, obstetric complications. TUMORS: See Neoplasms
For cervical cancer. (GL) 102(3):185 102(3):143
¢ For colorectal cancer, pros and cons. 102(1): SOCIAL PROBLEMS ULCER
48* ¢ Pathological gambling, social and medical is- ¢ Peptic, historical overview. (FT) 102(5):158
¢ For HIV in pregnant women, pros and cons. sue. (ED) 102(4):13 UROLOGIC DISEASES
102(1):77* SOCIAL RESPONSIBILITY ¢ Chronic renal failure, peripheral neuropathy,
¢ For iron overload disease, recommendations. ¢ Physician volunteerism, opportunities and re- presentations and therapeutic approaches.
102(6):90 wards. (ED) 102(1):13 102(4):249*
¢ For mouth disorders in patients with diabetes. SUBSTANCE ABUSE ¢ Common conditions, management in primary
102(6):117* ¢ In pregnancy, detection, intervention, and care setting. 102(2):235*
¢ For skin cancer. 102(2):152 support. 102(3):135* * Oliguria in critically ill patients, treatment.
¢ For substance abuse in pregnancy. 102(3): SURGERY 102(3):245*
137 ¢ For medically intractable epilepsy. 102(1):112
¢ Lipid, in children and adolescents to identify ¢ For ovarian cancer. 102(3):115 VACCINATION: See Immunization
patients with familial hypercholesterolemia. ¢ Gastric, for cancer, methods and benefits. VIRAL DISEASES
(GL) 102(1):218 102(4):234 * Hepatitis A and B, latest recommendations on
¢ Methods in early detection of ovarian cancer. ¢ Hysterectomy, guidelines for cost-effective vaccination. 102(6):74*
102(3):112 and quality treatment. 102(3):153* * Hepatitis C, controversies in diagnosis and
SEIZURES ¢ Liver transplantation, patient referral, indica- treatment. 102(5):201*
¢ Epilepsy, issues in medical and surgical treat- tions and contraindications. 102(6):103* * Hepatits C, diagnosis and management, from
ment. 102(1):102* ¢ Renal transplantation, effect on polyneuropathy transmission to long-term follow-up. 102(6):95*
¢ In children, the elderly, and patients with co- in patients with chronic renal failure. 102(4):256 ¢ HIV infection in women and children, special
existent medical illness, special management concerns in care and prevention. 102(4):165*
considerations. 102(1):165* TECHNOLOGY, MEDICAL ¢ HIV infection, screening pregnant women,
¢ In women, special concerns. 102(1):123* ¢ Diagnostic imaging, historical overview, find- pros and cons. 102(1):77*
¢ Management, five new antiepileptic drugs. ing new ways to see and cure. (FT) 102(6):144 HIV infection, successes and challenges with
102(1):147* ¢ Pacemaker therapy, indications for temporary use of antiretroviral therapy. 102(4):100*
SEXUAL DISORDERS and permanent placement after acute myocar- * Poliovirus, new vaccination recommenda-
¢ In patients with epilepsy. 102(1):127 dial infarction. 102(5):133 tions. 102(5):45*
continued
VOL 102 / NO 6 / DECEMBER 1997 / POSTGRADUATE MEDICINE 161
INDEX TO VOLUME 102 CONTINUED
¢ Primary HIV infection, clinical features and ¢ Elderly, with vulvar problems, identification ¢ Pregnant, mandatory screening for HIV infec-
laboratory tests for early diagnosis. 102(4):143* and treatment. 102(3):121* tion, pros and cons. 102(1):77*
¢ Varicelia-zoster virus infection, new develop- ¢ Hormone replacement therapy. (PN) 102(3):290 e Substance abuse in pregnancy, detection, in-
ments in prevention and treatment. 102(1):187* ¢ Hysterectomy, guidelines for surgical options. tervention, and support. 102(3):135*
VITAMINS 102(3):153* ¢ With epilepsy, special gender-related con-
¢ E, supplemental, benefits. 102(2):199* ° Mastalgia, causes, evaluation, and treatment. cerns. 102(1):123*
102(5):183* e With HIV infection, special concerns in care
WOMEN * Ovarian cancer, screening, prevention, and and prevention. 102(4):165*
¢ Cervical cancer screening. (GL) 102(3):185 management. 102(3):112*
Authors
ANDERSON EG CERDA JJ FAXON DP
Doc Anderson’s lost and found: When serendip- See Verne GN Thrombolytic therapy versus primary angio-
ity is reflected as brilliance. (PH) 102(4):23 CONRAD DA plasty: Which offers the best outcome after my-
Listening to Mama. (PH) 102(2):25 New recommendations for poliovirus vaccina- ocardial infarction? 102(5):97
tion: Combination regimen captures best effects FEDERMAN AS
BARHAN S$ of available vaccines. 102(5):45 See Federman DG [102(1):29]
Vulvar problems in elderly women: Don’t as- COULTER CH FEDERMAN DG
sume that menopause is the culprit. 102(3):121 Physician organizations: A viable alternative to The certainty of uncertainty: In spite of our best
BAUM N today’s HMOs? (ED) 102(2):13 efforts, we can’t always explain the outcomes.
See Gottesman J CRUIKSHANK SH (PH) 102(5):33
BERGERON BP Introduction to symposium on women’s health- Sibling rivalry? Two physician brothers and the
Usable voice-recognition technology: It’s fi- care. 102(3):109 accident that changed their view of the profes-
nally arrived! (DD) 102(5):39 sion. (PH) 102(1):29
BRADY WM deBOISBLANC BP FELDMAN J
Controversies in diagnosis and treatment of See Thomas DA See Henry K
hepatitis C: Which patients benefit most from DePRIEST J FINNEY LS
therapy? 102(5):201 Reversing oliguria in critically ill patients: What the mouth has to say about diabetes:
BRANDSTETTER RD Volume loading, diuretics, and continuous renal Careful examinations can avert serious compli-
See Lomotan JR replacement therapy. 102(3):245 cations. 102(6):117
BRODY MB DOLAN SA FINNEY MO
Varicella-zoster virus infection: The complex Vaccines for hepatitis A and B: The latest rec- See Finney LS
prevention-treatment picture. 102(1):187 ommendations on safe and extended protection.
BUCHANAN A 102(6):74 GEORGE SS
Congestive heart failure in elderly patients: See Lomotan JR
The treatment goal is improved quality, not EARLY DS GONZALEZ-CAMPOY JM
quantity, of life. 102(4):207 Is routine screening for colorectal cancer justi- See Finney LS
BUCURESCU G fiable? These gastroenterologists say YES! GOODMAN R
See Sperling MR 102(1):48 Multiple myeloma: Diagnostic clues in a patient
ENNIS KJ presenting with incapacitating arthralgias. (CR)
CAPIZZI SA Maximizing drug compliance in the elderly: 102(4):197
Rheumatic fever revisited: Keep this diagnosis Tips for staying on top of your patients’ medica- GOTTESMAN J
on your list of suspects. (CR) 102(6):65 tion use. 102(3):211 Common urologic disorders: When to treat and
CAVERT W ENRIQUEZ-SARANO M when to refer. 102(2):235
Preventing and treating major opportunistic in- See Capizzi SA GRUNDY SM
fections in AIDS: What’s new and what's still EZENAGU L Cholestero! management in patients with heart
true. 102(4):125 See Barhan S disease: Emphasizing secondary prevention to
increase longevity. 102(2):81
continued on page 166
162
INDEX TO VOLUME 102 CONTINUED
HADLER NM JACOTT WE LAVIE CJ
Fibromyalgia, chronic fatigue, and other iatro- The future of graduate medical education: An Coronary heart disease: From early defeats to
genic diagnostic algorithms: Do some labels issue that will affect all of us. (ED) 102(6):15 current victories, the battle continues. (FT)
escalate illness in vulnerable patients? (VP) JANOFF EN 102(2):210
102(2):161 See Rubins JB LEGWOLD G
HARDING J JENSON HB See Lavie CJ; Montgomery JL
The ethics of managed care: Doing the right See Conrad DA LEVY NT
thing might take more than instinct. (ED) 102(3):15 See Capizzi SA
HARPHAM WS KANKAM CG LIBANATI C
Raising the curtain on cancer: |s the puzzle fi- Acute sinusitis in adults: Difficult to diagnose, See Goodman R
nally becoming clear? (FT) 102(3):232 essential to treat. 102(2):253 LIPORACE JD
HARRIS MJ KAPLAN LA Women’s issues in epilepsy: Menses, child-
Psychosis in late life: Spotting new-onset dis- See Mafong EA bearing, and more. 102(1):123
orders in your elderly patients. 102(6):139 KAUR P See also Sirven JI
HENRY K Document imaging in medicine: How long can LOMOTAN JR
Antiretroviral therapy for HIV infection: Heart- you do without it? (DD) 102(1):19 Aspiration pneumonia: Strategies for early
ening successes mixed with continuing chal- KIM B recognition and prevention. 102(2):225
lenges. 102(4):100 See Sperling MR LUXON BA
Introduction to symposium on HIV/AIDS. KING JC Liver transplantation: Who should be referred
102(4):97 Substance abuse in pregnancy: A bigger prob- —and when? 102(6):103
HOEL D lem than you think. 102(3):135
See Arvey Al; Harpham WS; Howard RB; O’Brien KING PD McDONNELL SM
ME Introduction to symposium on hepatic disor- Hereditary hemochromatosis: Preventing
HOWARD RB ders. 102(6):72 chronic effects of this underdiagnosed disorder.
Beyond Windy Acres: A physician’s personal ex- KIRCHNER JT 102(6):83
perience with long-term care. (PH) 102(3):29 Psittacosis: Is contact with birds causing your MAFONG EA
Grow old along with me: A look at the new face patient’s pneumonia? 102(2):181 Insect repellents: What really works? 102(2):63
of aging. (FT) 102(4):216 KLIGMAN AM MARGHOOB AA
Letter from a virtual physician—2047: A little Topical treatments for photoaged skin: Basal and squamous cell carcinomas: What
fantasy from the future of medicine. (PH) Separating the reality from the hype. 102(2):115 every primary care physician should know.
102(6):25 KOCHAR MS 102(2):139
HOYT L Calcium channel blockers: Consensus amid MARSHALL JB
HIV infection in women and children: Special controversy. 102(6):127 See Early DS
concerns in prevention and care. 102(4):165 KORETZ RL MATTHIES RW
HULIHAN JF Is routine screening for colorectal cancer justi- How to spot depressed patients in your prac-
Seizures in special populations: Children, the fiable? This gastroenterologist says NO! 102(1): tice. 102(2):219
elderly, and patients with coexistent medical ill- 49 MEISLER JG
ness. 102(1):165 KOVAC SR See Meydani M
Which route for hysterectomy? Evidence-based MERCER DW
INSTITUTE FOR CLINICAL SYSTEMS outcomes guide selection. 102(3):153 Role of cardiac markers in evaluation of sus-
INTEGRATION pected myocardial infarction: Selecting the
Adult degenerative joint disease of the knee: LANDOW K most clinically useful indicators. 102(5):113
Maximizing function and promoting joint health. Dispelling myths about acne. 102(2):94 MERIGGIOLI MN
(GL) 102(5):167 Introduction to symposium on skin disorders. Peripheral neuropathy and connective tissue
Cervical cancer screening: Pap smears. (GL) 102(2):93 disease: Watch for this twosome when hunting
102(3):185 LARSEN RR for a diagnosis. 102(5):65
Lipid screening in children and adolescents: Who are the winners in managed care? A look MEYDANI M
Identifying patients with familial hypercholes- at how physicians, hospitals, patients, and oth- A closer look at vitamin E: Can this antioxidant
terolemia. (GL) 102(1):218 ers are faring. (ED) 102(5):13 prevent chronic diseases? 102(2):199
LATIF A MISHRIKI YY
Gastric cancer: Update on diagnosis, staging, The case of the creeping papules. (PP)
and therapy. 102(4):231 102(6):41
continued